These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25262866)

  • 1. Ablation of the epicardial substrate in the right ventricular outflow tract in a patient with Brugada syndrome refusing implantable cardioverter defibrillator therapy.
    Széplaki G; Özcan EE; Osztheimer I; Tahin T; Merkely B; Gellér L
    Can J Cardiol; 2014 Oct; 30(10):1249.e9-1249.e11. PubMed ID: 25262866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation.
    Brugada J; Pappone C; Berruezo A; Vicedomini G; Manguso F; Ciconte G; Giannelli L; Santinelli V
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1373-81. PubMed ID: 26291334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium.
    Nademanee K; Veerakul G; Chandanamattha P; Chaothawee L; Ariyachaipanich A; Jirasirirojanakorn K; Likittanasombat K; Bhuripanyo K; Ngarmukos T
    Circulation; 2011 Mar; 123(12):1270-9. PubMed ID: 21403098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the epicardial substrate for catheter ablation of Brugada syndrome.
    Zhang P; Tung R; Zhang Z; Sheng X; Liu Q; Jiang R; Sun Y; Chen S; Yu L; Ye Y; Fu G; Shivkumar K; Jiang C
    Heart Rhythm; 2016 Nov; 13(11):2151-2158. PubMed ID: 27453126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of catheter ablation in high-risk patients with Brugada syndrome refusing an implantable cardioverter defibrillator implantation.
    Li L; Ding L; Zhou L; Wu L; Zheng L; Zhang Z; Xiong Y; Zhang Z; Yao Y
    Europace; 2023 Dec; 26(1):. PubMed ID: 37889958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry).
    Nademanee K; Chung FP; Sacher F; Nogami A; Nakagawa H; Jiang C; Hocini M; Behr E; Veerakul G; Jan Smit J; Wilde AAM; Chen SA; Yamashiro K; Sakamoto Y; Morishima I; Das MK; Khongphatthanayothin A; Vardhanabhuti S; Haissaguerre M
    Circulation; 2023 May; 147(21):1568-1578. PubMed ID: 36960730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial ablation utilizing remote magnetic navigation in a patient with Brugada syndrome and inferior early repolarization.
    Lim PCY; Nademanee K; Lee ECY; Teo WS
    Pacing Clin Electrophysiol; 2018 Feb; 41(2):214-217. PubMed ID: 28842979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid thoracoscopic epicardial ablation of right ventricular outflow tract in patients with Brugada syndrome.
    Salghetti F; de Asmundis C; Sieira J; Coutiño HE; Abugattas JP; Varnavas V; Maj R; Terasawa M; Guimarães Osório T; Stroker E; Capulzini L; Iacopino S; Paparella G; Umbrain V; Poelaert J; Van Dooren S; Brugada P; Chierchia GB; La Meir M
    Heart Rhythm; 2019 Jun; 16(6):879-887. PubMed ID: 30594641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation.
    Sairaku A; Yoshida Y; Nakano Y; Kihara Y
    Int J Cardiol; 2013 Oct; 168(6):5273-6. PubMed ID: 23988302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epicardial ablation for prevention of ventricular fibrillation in a patient with Brugada syndrome.
    Cortez-Dias N; Plácido R; Marta L; Bernardes A; Sobral S; Carpinteiro L; de Sousa J
    Rev Port Cardiol; 2014 May; 33(5):305.e1-7. PubMed ID: 24931179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.
    Bai R; Di Biase L; Shivkumar K; Mohanty P; Tung R; Santangeli P; Saenz LC; Vacca M; Verma A; Khaykin Y; Mohanty S; Burkhardt JD; Hongo R; Beheiry S; Dello Russo A; Casella M; Pelargonio G; Santarelli P; Sanchez J; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):478-85. PubMed ID: 21665983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation for the treatment of Brugada syndrome: current status and future prospects.
    Rizzo A; de Asmundis C; Brugada P; La Meir M; Chierchia GB
    Expert Rev Med Devices; 2020 Feb; 17(2):123-130. PubMed ID: 31986921
    [No Abstract]   [Full Text] [Related]  

  • 13. [The electrophysiological study and implantable cardioverter defibrillator therapy for the patients with Brugada syndrome].
    Shan QJ; Yang B; Chen ML; Zou JG; Xu DJ; Chen C; Li KL; Zhu PJ; Wang XB; Cao KJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jan; 33(1):34-6. PubMed ID: 15924775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic ventricular fibrillation.
    Tilz RR; Fedele L; Satomi K; Kuck KH; Antz M
    Herz; 2007 May; 32(3):233-9. PubMed ID: 17497257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
    Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk Brugada syndrome: factors associated with arrhythmia recurrence and benefits of epicardial ablation in addition to implantable cardioverter defibrillator implantation.
    Santinelli V; Ciconte G; Manguso F; Anastasia L; Micaglio E; Calovic Z; Vicedomini G; Mazza B; Vecchi M; Mecarocci V; Locati ET; Boccellino A; Negro G; Napolano A; Giannelli L; Pappone C
    Europace; 2023 Dec; 26(1):. PubMed ID: 38252933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation for electrical storm in Brugada syndrome: Results of substrate based ablation.
    Shelke A; Tachil A; Saggu D; Jesuraj ML; Yalagudri S; Narasimhan C
    Indian Heart J; 2018; 70(2):296-302. PubMed ID: 29716710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epicardial radiofrequency catheter ablation of Brugada syndrome with electrical storm during ventricular fibrillation: A case report.
    Jiang S; Yin X; Dong C; Xia Y; Liu J
    Medicine (Baltimore); 2017 Nov; 96(46):e8688. PubMed ID: 29145303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel method to enhance phenotype, epicardial functional substrates, and ventricular tachyarrhythmias in Brugada syndrome.
    Chung FP; Raharjo SB; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Lin CY; Chang YT; Hung Y; Te A; Yamada S; Tasaka H; Wang CT; Chen SA
    Heart Rhythm; 2017 Apr; 14(4):508-517. PubMed ID: 28065832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Endocardial Ablation of Drug-Resistant Ventricular Fibrillation in Brugada Syndrome: Long-Term Outcome.
    Talib AK; Takagi M; Shimane A; Nakano M; Hayashi T; Okajima K; Kentaro M; Fukada K; Kowase S; Kurosaki K; Nitta J; Nishizaki M; Yui Y; Talib A; Sato N; Kawamura Y; Hasebe N; Aita S; Sai E; Komatsu Y; Kuroki K; Kaneshiro T; Dongzu X; Tajiri K; Igarashi M; Yamasaki H; Murakoshi N; Kumagai K; Sekiguchi Y; Nogami A; Aonuma K
    Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e005631. PubMed ID: 30354308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.